Stay updated on Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision tag was updated from v3.5.4 to v3.5.5, indicating a newer software release. This change is a backend/version update and does not modify study content or user-visible data.SummaryDifference0.0%

- Check8 days agoChange DetectedA new version entry on 2026-05-26 adds updates to the Study Status and Contacts/Locations sections, signaling updated recruitment status and contact details for the trial.SummaryDifference0.2%

- Check15 days agoChange DetectedA new revision on 2026-05-18 adds Contacts/Locations and Study Status to the record history, indicating updated site information and recruitment status. The 2026-04-17 entry was removed from the history.SummaryDifference0.2%

- Check22 days agoChange DetectedThe footer revision label changed from v3.5.3 to v3.5.4, signaling an update to the page.SummaryDifference0.0%

- Check36 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3, indicating a new build of the page. The update appears in the page footer as the current revision.SummaryDifference0.0%

- Check43 days agoChange DetectedThe record history reflects recent updates to Study Status and Contacts/Locations for the study, along with a new version submitted on 2026-04-17. One earlier version entry (2026-04-02) was removed from the history list.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.